GRF (Human)

<strong>GRF (Human)</strong> <strong>Catalog number:</strong> MDP0496 <strong>CAS Number: </strong>120796-99-8 <strong>Sequence: </strong>Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 <strong>Amount:</strong> 500 ug <strong>Molecular Weight:</strong> 5039.6 g/mol <strong>Supplied as:</strong> Powder <strong>Applications:</strong> molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals. <strong>Grade:</strong> Biotechnology grade. All products are highly pure. <strong>References:</strong> 1: Barker LA, Harry JR, Mercer JA. Relationships Between Countermovement Jump Ground Reaction Forces and Jump Height, Reactive Strength Index, and Jump Time J Strength Cond Res. 2018 Jan;32(1):248-254. 2: Böhlen P, Brazeau P, Bloch B, Ling N, Gaillard R, Guillemin R. Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40 Biochem Biophys Res Commun. 1983 Aug 12;114(3):930-6. 3: Zare Jeddi M, Virgolino A, Fantke P, Hopf NB, Galea KS, Remy S, Viegas S, Mustieles V, Fernandez MF, von Goetz N, Vicente JL, Slobodnik J, Rambaud L, Denys S, St-Amand A, Nakayama SF, Santonen T, Barouki R, Pasanen-Kase R, Mol HGJ, Vermeire T, Jones K, Silva MJ, Louro H, van der Voet H, Duca RC, Verhagen H, Canova C, van Klaveren J, Kolossa-Gehring M, Bessems J. A human biomonitoring (HBM) Global Registry Framework: Further advancement of HBM research following the FAIR principles Int J Hyg Environ Health. 2021 Sep;238:113826. 4: Rodriguez AA, Wojtaszek JL, Greer BH, Haldar T, Gates KS, Williams RS, Eichman BF. An autoinhibitory role for the GRF zinc finger domain of DNA glycosylase NEIL3 J Biol Chem. 2020 Nov 13;295(46):15566-15575. 5: Yamauchi J, Koyama K. The mechanical role of the metatarsophalangeal joint in human jumping PLoS One. 2022 May 20;17(5):e0268634. 6: Campbell RM, Stricker P, Miller R, Bongers J, Liu W, Lambros T, Ahmad M, Felix AM, Heimer EP. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences Peptides. 1994;15(3):489-95. 7: Laburthe M, Couvineau A, Rouyer-Fessard C. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat Mol Pharmacol. 1986 Jan;29(1):23-7. 8: Esposito P, Barbero L, Caccia P, Caliceti P, D'Antonio M, Piquet G, Veronese FM. PEGylation of growth hormone-releasing hormone (GRF) analogues Adv Drug Deliv Rev. 2003 Sep 26;55(10):1279-91. 9: Sugihara H, Wakabayashi I, Minami S, Takahashi F, Shibasaki T, Ling N. Effect of alpha-methyl-p-tyrosine and an antiserum to rat growth hormone (GH)-releasing factor (GRF) on plasma GH secretory profile during a continuous infusion of human GRF in rats Brain Res. 1988 Dec 13;475(1):128-33. <a href="https://pubmed.ncbi.nlm.nih.gov/35911193">10: Mauersberger M, Hähnel F, Wolf K, Markmiller JFC, Knorr A, Krumm D, Odenwald S. Predicting ground reaction forces of human gait using a simple bipedal spring-mass model R Soc Open Sci. 2022 Jul 27;9(7):211582. </a> <br><strong>Products Related to GRF (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>